Does CABAZITAXEL Cause Febrile neutropenia? 197 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 197 reports of Febrile neutropenia have been filed in association with CABAZITAXEL (Jevtana). This represents 7.7% of all adverse event reports for CABAZITAXEL.
197
Reports of Febrile neutropenia with CABAZITAXEL
7.7%
of all CABAZITAXEL reports
66
Deaths
119
Hospitalizations
How Dangerous Is Febrile neutropenia From CABAZITAXEL?
Of the 197 reports, 66 (33.5%) resulted in death, 119 (60.4%) required hospitalization, and 26 (13.2%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
Dyspnoea (113)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which CABAZITAXEL Alternatives Have Lower Febrile neutropenia Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE